Updated:
Titan Spine
Titan Spine is a US-based company founded in 2006 in Mequon. It designs and manufactures interbody fusion devices for the spine. The company has secured $34.1...
Titan Spine
Titan Spine is a US-based company founded in 2006 in Mequon. It designs and manufactures interbody fusion devices for the spine. The company has secured $34.1 million in total funding.
General information
Firm type
other
Year founded
2005
Location
Region
North America
Country
United States
City
Milwaukee
Corporate office
Milwaukee, WI, United States
Additional offices
San Diego, CA, United States
Principals
Kevin Gemas
President & CEO
Sector focus
Frequently asked questions
What is Titan Spine's core technology?
Titan Spine developed a subtractive manufacturing process that creates a nanoscale textured titanium surface without coatings or additives. The surface topography is designed to stimulate osteoblast activity and trigger a cellular-level response for bone fusion. The company held over 40 patents on this approach, which it marketed under the name nanoLOCK.
Is Titan Spine still an independent company?
No. Medtronic plc acquired Titan Spine in August 2021 (per Medtronic, August 2021), and the company no longer operates as a standalone entity. Its implant portfolio and surface technology were integrated into Medtronic's Spinal & Biologics division.
What spinal implant products did Titan Spine commercialize?
Titan Spine's product line included the Endoskeleton and PLATEAU families of interbody fusion devices for lumbar and cervical spine procedures. These implants were cleared by the FDA and sold primarily in the U.S., with some distribution in Australia and New Zealand.
How does Titan Spine's nano-surface technology differ from traditional spinal implants?
Traditional interbody cages use smooth or macro-roughened titanium or PEEK (polyetheretherketone) plastic, sometimes with sprayed-on coatings like hydroxyapatite. Titan Spine's technology textures the implant surface at the sub-micron level through a controlled etching process, which published research showed increases osteogenic and anti-inflammatory responses compared to smooth titanium or PEEK.
Who ran Titan Spine prior to the Medtronic acquisition?
Kevin Gemas served as President and CEO of Titan Spine. He led the company through its FDA clearances, commercialization phase, and ultimately the sale to Medtronic in 2021.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: